- The Wall Street Journal reported that Baxter International Inc (NYSE:BAX) is reportedly in advanced talks to Hill-Rom Holdings Inc (NYSE:HRC) for about $10 billion, citing people familiar with the matter.
- The report said a takeover deal could value Hill-Rom at around $150 per share, and the agreement could be reached by midweek if the talks do not fall apart.
- The talks follow an earlier bid from Baxter worth $144/share that Hill-Rom rebuffed.
- Related Content: Baxter In Early Talks To Acquire Hill Rom
- Hill-Rom currently has nearly $9 billion market capitalization, while Baxter’s is around $37 billion.
- Price Action: BAX stock is trading 0.99% higher at $74.70, and HRC stock is up 8.35% at $144 in the premarket session on the last check Monday.
AstraZeneca’s COVID-19 Antibody Treatment Scores Approval In Europe
The European Commission has approved AstraZeneca plc’s (NASDAQ:AZN) Evusheld (tixagevimab and cilgavimab, formerly AZD7442), a long-acting antibody combination as COVID-19 treatment…
